Garsorasib

Modify Date: 2025-08-27 16:43:24

Garsorasib structure	Common Name	Garsorasib
	CAS Number	2559761-14-5	Molecular Weight	598.65
	Density	N/A	Boiling Point	N/A
	Molecular Formula	C₃₂H₃₂F₂N₈O₂	Melting Point	N/A
	MSDS	N/A	Flash Point	N/A

Use of Garsorasib

Garsorasib is a potent inhibitor of KRAS G12C with an IC50 of 10 nM. Garsorasib has the potential for the research of various cancer such as pancreatic cancer, endometrial cancer, colorectal cancer, or lung cancer (non-small cell lung cancer) (extracted from patent WO2020233592A1, compound 2)[1].

Name	Garsorasib

Description	Garsorasib is a potent inhibitor of KRAS G12C with an IC50 of 10 nM. Garsorasib has the potential for the research of various cancer such as pancreatic cancer, endometrial cancer, colorectal cancer, or lung cancer (non-small cell lung cancer) (extracted from patent WO2020233592A1, compound 2)[1].
Related Catalog	Research Areas >> Cancer Signaling Pathways >> GPCR/G Protein >> Ras
Target	KRas G12C
References	[1]. Wang, Lisha, et al. Cbp/ep300 inhibitor and use thereof. Patent WO2021213521A1.

Molecular Formula	C₃₂H₃₂F₂N₈O₂
Molecular Weight	598.65

The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.

Garsorasib

Use of Garsorasib

Names

Garsorasib Biological Activity

Chemical & Physical Properties

The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.